A new flu vaccine geared to older people is coming soon
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker
7 sourcesHeat 4.4Updated Aug 6
A new flu vaccine geared to older people is coming soon
7 articles from NPR, The Guardian Health, NPR Health, Ars Technica and 3 more.
News Clarion synthesisAcross 7 sources
The FDA has approved mFLUSIVA, Moderna's mRNA-based flu vaccine, marking the first flu shot made with messenger RNA technology. The vaccine is approved for adults ages 50 and up and will be available for the upcoming flu season. The approval came after the FDA initially refused to review the application before reversing course.
AI-generated summary of 7 source articles. Not original reporting — every claim links to its source below.
How outlets framed it
4 anglesmRNA technology as continuity from Covid
These outlets frame the approval primarily as an extension of mRNA platform success, emphasizing how the same technology behind the Covid vaccine now applies to flu. The Guardian explicitly connects the flu vaccine to ending the coronavirus pandemic.
The Guardian Health
FDA approval milestone for mRNA flu vaccine
Multiple outlets lead with the regulatory achievement itself—the FDA's approval of the first mRNA flu shot—treating this as the newsworthy event without foregrounding the technology's prior use.
Time · STAT News
Moderna product approval with eligibility details
These outlets focus on the vaccine approval as a Moderna product moment, including specific product names and age eligibility rather than emphasizing the technological innovation.
Ars Technica · NPR
FDA process and initial regulatory resistance
This outlet uniquely frames the story around the FDA's decision-making process itself, noting that the agency initially refused to review the approval request before eventually approving it.
Live Science
AI analysis of how 7 publishers framed this story, based on their headlines and summaries. A description of the coverage, not a judgement of any outlet.
Full coverage
The mRNA technology behind Moderna’s Covid vaccine reaches the flu
The mFlusiva vaccine for older people is first made with mRNA platform key to ending coronavirus pandemic The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the Covid -19…
An FDA decision could give us the first mRNA flu vaccine
The Food and Drug Administration is expected to decide whether to approve the first mRNA flu vaccine.
Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
FDA Approves the First mRNA Flu Vaccine
The shot, made by Moderna, will be available for this year's upcoming flu season.
FDA approves Moderna’s mRNA flu vaccine, the first to use the technology
The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.
FDA approves first mRNA vaccine for seasonal flu
The Food and Drug Administration's approval of an mRNA vaccine for flu comes after the agency initially refused to review the approval request for the shot.
